[HTML][HTML] Identification of bioactive molecules from Triphala (Ayurvedic herbal formulation) as potential inhibitors of SARS-CoV-2 main protease (Mpro) through …

M Rudrapal, I Celik, J Khan, MA Ansari… - Journal of King Saud …, 2022 - Elsevier
Severe acute respiratory syndrome coronavirus disease (SARS-CoV-2) induced coronavirus
disease 2019 (COVID-19) pandemic is the present worldwide health emergency. The global …

Anthocyanin derivatives as potent inhibitors of SARS-CoV-2 main protease: An in-silico perspective of therapeutic targets against COVID-19 pandemic

Z Fakhar, B Faramarzi, S Pacifico… - Journal of Biomolecular …, 2021 - Taylor & Francis
A new pathogen severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has
spread worldwide and become pandemic with thousands new deaths and infected cases …

Molecular docking and dynamic simulations of some medicinal plants compounds against SARS-CoV-2: an in silico study

IA Adejoro, DD Babatunde… - Journal of Taibah …, 2020 - Taylor & Francis
ABSTRACT COVID-19 pandemic has poses urgent health challenge, and this project aims
to identify potential inhibitors to combat this virus. We screened 198 bioactive compounds …

In silico screening predicts common cold drug Dextromethorphan along with Prednisolone and Dexamethasone can be effective against novel Coronavirus disease …

I Sarkar, A Sen - Journal of Biomolecular Structure and Dynamics, 2022 - Taylor & Francis
The ongoing outbreak of Coronavirus disease 2019 (COVID-19) is a matter of great concern.
Although the mortality rate caused by this virus is less than that of SARS and MERS, it is …

Molecular Docking Studies on the Anti-viral Effects of Compounds From Kabasura Kudineer on SARS-CoV-2 3CLpro

S Vincent, S Arokiyaraj, M Saravanan… - Frontiers in molecular …, 2020 - frontiersin.org
The COVID-19 has now been declared a global pandemic by the World Health
Organization. No approved drug is currently available; therefore, an urgent need has been …

Structure-based drug designing for potential antiviral activity of selected natural products from Ayurveda against SARS-CoV-2 spike glycoprotein and its cellular …

VK Maurya, S Kumar, AK Prasad, MLB Bhatt… - Virusdisease, 2020 - Springer
The recent outbreak of COVID-19 caused by SARS-CoV-2 brought a great global public
health and economic concern. SARS-CoV-2 is an enveloped RNA virus, from the genus …

[HTML][HTML] Potential inhibitors of SARS-CoV-2 (COVID 19) proteases PLpro and Mpro/3CLpro: molecular docking and simulation studies of three pertinent medicinal …

D Verma, D Mitra, M Paul, P Chaudhary… - Current Research in …, 2021 - Elsevier
The rapid spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-
coronavirus disease 2019 (COVID-19) has raised a severe global public health issue and …

Inhibition of SARS-CoV-2 main protease by phenolic compounds from Manilkara hexandra (Roxb.) Dubard assisted by metabolite profiling and in silico virtual …

FM Abd El-Mordy, MM El-Hamouly, MT Ibrahim… - RSC …, 2020 - pubs.rsc.org
SARS-CoV-2 is a novel coronavirus that was first identified during the outbreak in Wuhan,
China in 2019. It is an acute respiratory illness that can transfer among human beings …

Secondary metabolites from spice and herbs as potential multitarget inhibitors of SARS-CoV-2 proteins

S Gupta, V Singh, PK Varadwaj… - Journal of …, 2022 - Taylor & Francis
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been responsible for
the current global pandemic that has caused a death toll of> 1.12 million worldwide and …

Sterenin M as a potential inhibitor of SARS-CoV-2 main protease identified from MeFSAT database using molecular docking, molecular dynamics simulation and …

J Prajapati, R Patel, D Goswami, M Saraf… - Computers in Biology …, 2021 - Elsevier
The disease outbreak of Coronavirus disease-19 (COVID-19), caused by the novel SARS-
CoV-2 virus, remains a public health concern. COVID-19 is spreading rapidly with a high …